Samsung Biologics (KRX: 207940.KS), a global contract development and manufacturing organization (CDMO), today announced ...

Samsung Biologics celebrated the 14th anniversary of its founding on Monday, marking its rise to become the world’s largest ...

Samsung Biologics reported consolidated revenue of KRW 1.3 trillion in the first quarter of 2025, mainly driven by the stable ramp-up of Plant 4 while maintaining the full utilization of Plants 1 ...

SEOUL, April 23 (Yonhap) -- Samsung Biologics Co., the biotech arm of South Korea's Samsung Group, said Wednesday its ...

"We sustained solid momentum in the first quarter, supported by the efficient operations across all our plants and continued partnerships with our clients," said John Rim, CEO and President of Samsung ...

FIRST QUARTER 2025 RESULTS Samsung Biologics reported consolidated revenue of KRW 1.3 trillion in the first quarter of 2025, mainly driven by the stable ramp-up of Plant 4 while maintaining the ...

Biogen’s lack of insider buying and reduced R&D spending raise concerns, but its future growth prospects remain. Find out why ...

Shares finished a tad lower Thursday as investors awaited tariff talks with the United States amid deepening concerns over ...